Company: EVLVW
Filing Date: 2025-04-28
Form Type: 10-Q
Source: 0001628280-25-020353
Chunk: 173

Company: Evolv Technologies Holdings, Inc.
Filing Date: 2025-04-28
Form: 10-Q
Item: Part I, Item 1
Chunk 173
---
 revenue of $2.2 million and $2.1 million for the three months ended September 30, 2024 and 2023, respectively, and $6.1 million and $9.1 million for the nine months ended September 30, 2024 and 2023, respectively.

The accompanying notes are an integral part of these condensed consolidated financial statements.

F-3

EVOLV TECHNOLOGIES HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(In thousands, except share amounts)

(Unaudited)

Common StockAdditionalPaid-inCapitalAccumulated Other Comprehensive Income (Loss)AccumulatedDeficitTotalStockholders’EquitySharesAmountBalances at December 31, 2023 (restated)151,310,080 $15 $444,825 $(53)$(300,647)$144,140 Issuance of common stock upon net exercise of stock options519,089 1 301 — — 302 Issuance of common stock upon vesting of restricted stock units3,527,778 — — — — — Stock-based compensation cost— — 6,605 — — 6,605 Cumulative translation adjustment— — — 3 — 3 Net loss (restated)— — — — (11,272)(11,272)Balances at March 31, 2024 (restated)155,356,947 $16 $451,731 $(50)$(311,919)$139,778 Issuance of common stock upon net exercise of stock options823,047 — 335 — — 335 Issuance of common stock upon vesting of restricted stock units1,294,128 — — — — — Stock-based compensation cost— — 7,679 — — 7,679 Cumulative translation adjustment— — — 8 — 8 Net income (restated)— — — — 3,418 3,418 Balances at June 30, 2024 (restated)157,474,122 $16 $459,745 $(42)$(308,501)$151,218 Issuance of common stock upon net exercise of stock options659,000 —